Ashanthi is the CEO & Co-founder of Pocket Naloxone Corp., introducing a game-changing opioid overdose rescue product to limit the 130 daily deaths in America while opening a new $1B+ OTC opportunity. Ashanthi has almost 20 years of experience in the healthcare industry. She founded and ran So Others May See, Inc., an award-winning social venture that, using a PHM approach, screened over 1.2 million schoolchildren for vision defects at $0.20/child and provided over 44,000 custom-fit eyeglasses at $6/pair. Ashanthi also served as VP of Marketing at SOC Telemed, the largest acute care provider of telemedicine services in the U.S., led forecasting and market research on a CV drug launch at Otsuka Pharma, and helped found the MedTech consulting practice at the Advisory Board Company. She has assisted a range of companies including Bayer, Medtronic, J&J, and Intuitive Surgical. B.S.E. (summa cum laude) Princeton, M.B.A. Stanford GSB.
Ashanthi Mathai, '95
CEO and Co-Founder, Pocket Naxolone